Injecting medicine into amniotic fluid shows promise for treating genetic disorders

Injecting medicine into the amniotic fluid staves off progression of spinal muscular atrophy in utero.  Evidence is mounting that clinicians can treat serious genetic disorders prenatally by injecting medicine into the amniotic fluid, thus preventing damage that begins in utero. A UC San Francisco-led study found that delivering medicine for spinal muscular atrophy (SMA) via … Read more

Late Amniocentesis is Safe With High Diagnostic Value

TOPLINE: Late amniocentesis demonstrates a 22.9% overall genetic diagnostic yield, with 2.4 times higher yield for fetuses with multiple organ system anomalies (36.4%) vs single organ system anomalies (15.3%). The procedure shows a low 1.2% complication rate, with delivery occurring at a median of 38 weeks 3 days gestation. METHODOLOGY: Researchers established a collaborative network … Read more